GMP Protein (E. coli) Contract Manufacturing Market Growth Accelerated by Microbial Contamination Control


 GMP Protein (E. coli) Contract Manufacturing plays a vital role in the biopharmaceutical industry as a host system for the recombinant production of therapeutic proteins. E. coli is a preferred host system due to its fast growth rate, well-characterized genetics, and the ability to produce complex proteins. However, microbial contamination during the fermentation and downstream processing remains a challenge. The global GMP Protein (E. coli) Contract Manufacturing Market is estimated to be valued at US$ 685.8 Mn in 2024 and is expected to exhibit a CAGR of 9.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
The use of single-use production technologies has accelerated over the last few years as they help eliminate cross-contamination risks. Single-use mixers, bioreactors, filtration systems are employed to manufacture proteins from a fermentation process conducted in single-use container bags instead of conventional stainless steel vessels. This mitigates the cleaning and contamination issues associated with reusable equipment. Several GMP Protein (E. coli) Contract Manufacturing players are now offering clients flexible and scalable production utilizing single-use systems to meet rising demand while ensuring strict quality practices for microbial contamination control.

Segment Analysis
The global GMP Protein (E. coli) Contract Manufacturing Market is dominated by the drug development segment, which accounts for over 30% share. This is because majority of recombinant therapeutic proteins are produced in E. coli due to its simple nutritional requirements, rapid growth, and ability to carry out post-translational modifications such as disulfide bond formation. Within the drug development segment, monoclonal antibody manufacturing sub-segment leads the market as biologics drug manufacturers increasingly rely on E. coli production for manufacturing antibodies in large commercial quantities.

Key Takeaways
The global GMP Protein (E. coli) Contract Manufacturing market is expected to witness high growth over the forecast period.

Regional analysis: North America is currently the largest as well as the fastest growing regional market. This is owing to presence of large number of CROs and pharma companies involved in manufacturing of biologics for widespread use across the region. Also, growing biosimilars industry is driving regional demand.

Key players: Key players operating in the GMP Protein (E. coli) Contract Manufacturing market are Merck & Co., Inc., Thermo Fisher Scientific Inc., Abcam plc, GenScript, and Creative Biolabs. Merck & Co., Inc. and Thermo Fisher Scientific Inc. collectively account for over 35% of the market share due to their extensive service and product portfolios for recombinant protein production.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more